eFFECTOR Therapeutics Inc...

0.00
-0.00 (-100.00%)
At close: Mar 06, 2025, 9:31 AM
0.00
0.00%
After-hours: Apr 01, 2025, 04:00 PM EDT

eFFECTOR Therapeutics Statistics

Share Statistics

eFFECTOR Therapeutics has 4.7M shares outstanding. The number of shares has increased by 0% in one year.

Shares Outstanding 4.7M
Shares Change (YoY) 0%
Shares Change (QoQ) 0%
Owned by Institutions (%) 1.28%
Shares Floating 4.66M
Failed to Deliver (FTD) Shares -
FTD / Avg. Volume < 0.01%

Short Selling Information

The latest short interest is 91.62K, so 1.95% of the outstanding shares have been sold short.

Short Interest 91.62K
Short % of Shares Out 1.95%
Short % of Float 2.17%
Short Ratio (days to cover) 0.97

Valuation Ratios

The PE ratio is -0.71 and the forward PE ratio is null. eFFECTOR Therapeutics's PEG ratio is -0.01.

PE Ratio -0.71
Forward PE n/a
PS Ratio 0
Forward PS null
PB Ratio -4.41
P/FCF Ratio -0.86
PEG Ratio -0.01
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for eFFECTOR Therapeutics.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.77, with a Debt / Equity ratio of -3.55.

Current Ratio 0.77
Quick Ratio 0.77
Debt / Equity -3.55
Debt / EBITDA -0.61
Debt / FCF -0.69
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $0
Profits Per Employee $-2.56M
Employee Count 14
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by null% in the last 52 weeks. The beta is 0.54, so eFFECTOR Therapeutics's price volatility has been higher than the market average.

Beta 0.54
52-Week Price Change null%
50-Day Moving Average 0
200-Day Moving Average 0.06
Relative Strength Index (RSI) 36.29
Average Volume (20 Days) -

Income Statement

Revenue n/a
Gross Profit -22.92M
Operating Income -33.84M
Net Income -35.81M
EBITDA -33.73M
EBIT -38.73M
Earnings Per Share (EPS) -16.37
Full Income Statement

Balance Sheet

The company has 14.88M in cash and 20.55M in debt, giving a net cash position of -5.67M.

Cash & Cash Equivalents 14.88M
Total Debt 20.55M
Net Cash -5.67M
Retained Earnings -179.38M
Total Assets 27.13M
Working Capital 681K
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -29.55M and capital expenditures -97K, giving a free cash flow of -29.65M.

Operating Cash Flow -29.55M
Capital Expenditures -97K
Free Cash Flow -29.65M
FCF Per Share -13.56
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

EFTR does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

Currently there are no analyst rating for EFTR.

Price Target $24
Price Target Difference n/a
Analyst Consensus Buy
Analyst Count 1
Stock Forecasts

Stock Splits

The last stock split was on Jan 12, 2024. It was a backward split with a ratio of 1:25.

Last Split Date Jan 12, 2024
Split Type backward
Split Ratio 1:25

Scores

Altman Z-Score -13.63
Piotroski F-Score 2